Cancer Drug Patent Issues: Delhi HC junks Bayer plea to block Natco Pharma Regonat Farhat Nasim15 July 2019 2:52 PM ISTNew Delhi: The Delhi High Court recently junked the injunction petition filed by the German Drugmaker to restrain the Hyderabad-based Natco Pharma...
Natco Pharma- Kothur facility gets 9 observations from USFDA Medical Dialogues Bureau7 Jun 2019 2:21 PM ISTNEW DELHI: Natco Pharma Thursday said the US health regulator has made nine observations after the completion of inspection of its Kothur formulation...
Swiss company Actelion moves US court against Natco Pharma over generic of its patented drug Medical Dialogues Bureau5 Jun 2019 12:27 PM ISTHyderabad: Swiss pharma company Actelion Pharmaceuticals Ltd has filed a petition in a US court alleging that Natco Pharma and its US partner Syneos...
Natco Pharma files ANDA for generic version of Bosentan tablets for oral suspension Farhat Nasim5 Jun 2019 10:00 AM ISTBosentan 32 mg tablets are sold by Actelion Pharmaceuticals US, Inc. (acquired by Johnson and Johnson) under the brand name Tracleer.Hyderabad:...
Natco Pharma settles patent litigation with Onyx Therapeutics over anti cancer drug- Kyprolis Medical Dialogues Bureau1 Jun 2019 2:39 PM ISTNew Delhi: Natco Pharma Thursday said it has settled patent litigation with Onyx Therapeutics Inc in the US over a generic version of Kyprolis, an...
Natco Pharma settles patent litigation over generic version of anti-cancer drug Kyprolis Medical Dialogues Bureau30 May 2019 5:12 PM ISTKyprolis is the trade name for the generic drug Carfilzomib. The anti-cancer drug is a targeted therapy and is classified as a Proteasome Inhibitor....
Natco Pharma Q4 PAT plunges to Rs 120 crore Garima28 May 2019 9:45 AM ISTThe company's board has declared a third interim dividend of Rs 1.25 per equity share of Rs 2 each, resulting in a total dividend payout of Rs 6.25...
Panacea Biotec gets USFDA nod for chemotherapy drug Azacitidine Farhat Nasim22 May 2019 9:45 AM ISTAzacitidine is a chemotherapy drug used to treat myelodysplastic syndromes (MDS) with annual sales of about USD 110 million in US markets as per IQVIA...
Natco Pharma marketing partner gets USFDA approval for Nitroglycerin Sublingual Tablets Farhat Nasim8 May 2019 10:15 AM ISTNitroglycerin sublingual tablets are used to treat episodes of angina (chest pain) in people who have coronary artery disease (narrowing of the blood...
Lupin, Natco receives USFDA nod for Imatinib Mesylate tablets Farhat Nasim6 March 2019 9:30 AM ISTImatinib Mesylate is a generic version of Novartis Pharmaceuticals Corporation's Gleevec tablets in the same strengths, Lupin said in a filing to BSE....
Natco Pharma raises Rs 915 crore via QIP Ruby Khatun Khatun15 Dec 2017 10:36 AM ISTNew Delhi: Natco Pharma has raised Rs 915 crore through issue of securities to qualified institutional investors (QIP), according to a regulatory...
Natco Pharma to invest Rs 100 crore in API facility in TN Ruby Khatun Khatun5 Oct 2017 11:12 AM ISTChennai: Nacto pharma is planning to invest in its existing facility and expand its Active Pharmaceutical Ingredient (API) and intermediates...
